FGF8, c-Abl and p300 participate in a pathway that controls stability and function of the ΔNp63α protein

Human Molecular Genetics

Volumn 24, Issue 15, 2015, Pages 4185-4197

  Restelli, Michela ^a   Molinari, Elisa ^a   Marinari, Barbara ^b   Conte, Daniele ^c   Gnesutta, Nerina ^a   Costanzo, Antonio ^b   Merlo, Giorgio Roberto ^c   Guerrini, Luisa ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; DELTANP63ALPHA PROTEIN; E1A ASSOCIATED P300 PROTEIN; FIBROBLAST GROWTH FACTOR 8; LYSINE; PROTEIN; TRICHOSTATIN A; TUMOR PROTEIN P73; UNCLASSIFIED DRUG; VALPROIC ACID; DNA BINDING PROTEIN; FGF8 PROTEIN, HUMAN; HISTONE ACETYLTRANSFERASE PCAF; PROTEIN BINDING; TP63 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA BINDING; ECTRODACTYLY; GENE LOSS; GENE MUTATION; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ACETYLATION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; ANIMAL; BIOSYNTHESIS; CELL LINE; CONGENITAL DISORDER; EMBRYO DEVELOPMENT; EMBRYOLOGY; GENE EXPRESSION REGULATION; GENETICS; LIMB MALFORMATION; METABOLISM; MOUSE; MUTATION; PATHOLOGY; PROMOTER REGION;

ANIMALS; CELL LINE; CONGENITAL ABNORMALITIES; DNA-BINDING PROTEINS; EMBRYONIC DEVELOPMENT; FIBROBLAST GROWTH FACTOR 8; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIMB DEFORMITIES, CONGENITAL; MICE; MUTATION; P300-CBP TRANSCRIPTION FACTORS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-ABL; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 85008702031     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddv151     Document Type: Article

References (58)

1. Koster, M.I., Kim, S., Mills, A.A., DeMayo, F.J. and Roop, D.R. (2004) p63 is the molecular switch for initiation of an epithelial stratification program. Genes Dev., 18, 126-133.
2. Yang, A., Kaghad, M., Wang, Y., Gillett, E., Fleming, M.D., Dötsch, V., Andrews, N.C., Caput, D. and McKeon, F. (1998) p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominantnegative activities. Mol. Cell, 2, 305-316.
3. Mills, A.A., Zheng, B., Wang, X.J., Vogel, H., Roop, D.R. and Bradley, A. (1999) p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature, 398, 708-713.
4. Yang, A., Schweitzer, R., Sun, D., Kaghad, M., Walker, N., Bronson, R.T., Tabin, C., Sharpe, A., Caput, D., Crum, C. and McKeon, F. (1999) p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature, 398, 714-718.
5. Bokhoven, H.V. and Brunner, H.G. (2002) Splitting p63. Am. J. Hum. Genet., 71, 1-13.
6. Brunner, H.G., Hamel, B.C.J. and Bokhoven, H.V. (2002) p63 gene mutations and human developmental syndromes. Am. J. Med. Genet., 112, 284-290.
7. Duijf, P.H., Bokhoven, H.V. and Brunner, H.G. (2003) Pathogenesis of split-hand/split-foot malformation. Hum. Mol. Genet., 12, 51-60.
8. Ianakiev, P., Kilpatrick, M.W., Toudjarska, I., Basel, D., Beighton, P. and Tsipouras, P. (2000) Split-hand/split-foot malformation is caused by mutations in the p63 Gene on 3q27. Am. J. Hum. Genet., 67, 59-66.
9. Guerrini, L., Costanzo, A. and Merlo, G.R. (2011) A symphony of regulations centered on p63 to control development of ectoderm-derived structures. J. Biomed. Biotechnol., 864904, doi:10.1155/2011/864904.
10. Murray-Zmijewski, F., Lane, D.P. and Bourdon, J.C. (2006) p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress. Cell Death Differ., 13, 962-972.
11. Mangiulli, M., Valletti, A., Caratozzolo, M.F., Tullo, A., Sbisà, E., Pesole, G. and D'Erchia, A.M. (2009) Identification and functional characterization of two new transcriptional variants of the human p63 gene. Nucleic Acids Res., 37, 6092-6104.
12. Harms, K.L. and Chen, X. (2006) The functional domains in p53 family proteins exhibit both common and distinct properties. Cell Death Differ., 13, 890-897.
13. Yang, A. and McKeon, F. (2000) p63 and p73: p53 mimics, menaces and more. Nat. Rev. Mol. Cell. Biol., 1, 199-207.
14. Yang, A., Kaghad, M., Caput, D. and McKeon, F. (2002) On the shoulder of giants: p63, p73 and the rise of p53. Trends Genet., 18, 90-95.
15. Irwin, M.S. and Kaelin, W.G. (2001) p53 family update: p73 and p63 develop their own identities. Cell Growth Differ., 1, 337-349.
16. Pozzi, S., Zambelli, F., Merico, D., Pavesi, G., Robert, A., Maltère, P., Gidrol, X., Mantovani, R. and Vigano, M.A. (2009) Transcriptional Network of p63 in human keratinocytes. PLoS ONE, 4, e5008.
17. Viganò, M.A. and Mantovani, R. (2007) Hitting the numbers: the emerging network of p63 targets. Cell Cycle, 3, 233-239.
18. Testoni, B., Borrelli, S., Tenedini, E., Alotto, D., Castagnoli, C., Piccolo, S., Tagliafico, E., Ferrari, S., Viganò, M.A. and Mantovani, R. (2006) Identification of newp63 targets in human keratinocytes. Cell Cycle, 5, 2805-2811.
19. Yu, K. and Ornitz, D.M. (2008) FGF signaling regulates mesenchymal differentiation and skeletal patterning along the limb bud proximodistal axis. Development, 135, 483-491.
20. Boulet, A.M., Moon, A.M., Arenkiel, B.R. and Capecchi, M.R. (2004) The roles of Fgf4 and FGF8 in limb bud initiation and outgrowth. Dev. Biol., 273, 361-372.
21. Moon, A.M. and Capecchi, M.R. (2000) FGF8 is required for outgrowth and patterning of the limbs. Nat. Genet., 26, 455-459.
22. Lewandoski, M., Sun, X. and Martin, G.R. (2004) FGF8 signalling from the AER is essential for normal limb development. Nat. Genet., 4, 460-463.
23. Restelli, M., Lopardo, T., Lo Iacono, N., Garaffo, G., Conte, D., Rustighi, A., Napoli, M., Del Sal, G., Perez-Morga, D., Costanzo, A., Merlo, G.R. and Guerrini, L. (2014) DLX5, FGF8 and the Pin1 isomerase control ΔNp63α protein stability during limb development: a regulatory loop at the basis of the SHFM and EEC congenital malformations. Hum. Mol. Genet., 23, 3830-3842.
24. Ghioni, P., D'Alessandra, Y., Mansueto, G., Jaffray, E., Hay, R.T., La Mantia, G. and Guerrini, L. (2005) The protein stability and transcriptional activity of p63alpha are regulated by SUMO-1 conjugation. Cell Cycle, 1, 183-190.
25. Galli, F., Rossi, M., D'Alessandra, Y., De Simone, M., Lopardo, T., Haupt, Y., Alsheich-Bartok, O., Anzi, S., Shaulian, E., Calabrò, V., La Mantia, G. and Guerrini, L. (2010) MDM2 and Fbw7 cooperate to induce p63 protein degradation following DNA damage and cell differentiation. J. Cell Sci., 123, 2423-2433.
26. Di Costanzo, A., Festa, L., Duverger, O., Vivo, M., Guerrini, L., La Mantia, G., Morasso, M.I. and Calabrò, V. (2009) Homeodomain protein Dlx3 induces phosphorylation-dependent p63 degradation. Cell Cycle, 8, 1185-1195.
27. Papoutsaki, M., Moretti, F., Lanza, M., Marinari, B., Sartorelli, V., Guerrini, L., Chimenti, S., Levrero, M. and Costanzo, A. (2005) A p38-dependent pathway regulates ?Np63 DNA binding to p53-dependent promoters in UV-induced apoptosis of keratinocytes. Oncogene, 24, 6970-6975.
28. Brooks, C.L. and Gu, W. (2003) Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr. Opin. Cell Biol., 15, 164-171.
29. Pietsch, E.C., Sykes, S.M., McMahon, S.B. and Murphy, M.E. (2008) The p53 family and programmed cell death. Oncogene, 50, 6507-6521.
30. Gu, B. and Zhu, W.G. (2012) Surf the post-translational modification network of p53 regulation. Int. J. Biol. Sci., 8, 672-684.
31. Brooks, C.L. and Gu, W. (2011) The impact of acetylation and deacetylation on the p53 pathway. Protein Cell, 2, 456-462.
32. Gu, W. and Roeder, R.G. (1997) Activation of p53 sequencespecific DNA binding by acetylation of the p53 C-terminal domain. Cell, 90, 595-606.
33. Luo, J., Li, M., Tang, Y., Laszkowska, M., Roeder, R.G. and Gu, W. (2004) Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A., 101, 2259-2264.
34. Marmorstein, R. and Roth, S.Y. (2001) Histone acetyltransferases: function, structure, and catalysis. Curr. Opin. Genet. Dev., 11, 155-161.
35. Zeng, X., Li, X., Miller, A., Yuan, Z., Yuan, W., Kwok, R.P., Goodman, R. and Lu, H. (2000) The N-terminal domain of p73 interacts with the CH1 domain of p300/CREB binding protein and mediates transcriptional activation and apoptosis. Mol. Cell Biol., 20, 1299-1310.
36. Costanzo, A., Merlo, P., Pediconi, N., Fulco, M., Sartorelli, V., Cole, P.A., Fontemaggi, G., Fanciulli, M., Schiltz, L., Blandino, G., Balsano, C. and Levrero, M. (2002) DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes. Mol. Cell, 9, 175-186.
37. Mantovani, F., Piazza, S., Gostissa, M., Strano, S., Zacchi, P., Mantovani, R., Blandino, G. and Del Sal, G. (2004) Pin1 links the activities of c-Abl and p300 in regulating p73 function. Mol. Cell, 14, 625-636.
38. Tang, Y., Zhao, W., Chen, Y., Zhao, Y. and Gu, W. (2008) Acetylation is indispensable for p53 activation. Cell, 133, 612-626.
39. Chae, Y.S., Kim, H., Kim, D., Lee, H. and Lee, H.O. (2012) Cell density-dependent acetylation of ΔNp63α is associated with p53-dependent cell cycle arrest. FEBS Lett., 8, 1128-1134.
40. Yan, W., Bentley, B. and Shao, R. (2008) Distinct angiogenic mediators are required for basic fibroblast growth factorand vascular endothelial growth factor-induced angiogenesis: the role of cytoplasmic tyrosine kinase c-Abl in tumor angiogenesis. Mol. Biol. Cell, 19, 2278-2288.
41. Agami, R., Blandino, G., Oren, M. and Shaul, Y. (1999) Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis. Nature, 399, 809-813.
42. Sanchez-Prieto, R., Sanchez-Arevalo, V.J., Servitja, J.M. and Gutkind, J.S. (2002) Regulation of p73 by c-Abl through the p38 MAP kinase pathway. Oncogene, 21, 974-979.
43. Levav-Cohen, Y., Goldberg, Z., Zuckerman, V., Grossman, T., Haupt, S. and Haupt, Y. (2005) C-Abl as a modulator of p53. Biochem. Biophys. Res. Commun., 331, 737-749.
44. Gonfloni, S., Di Tella, L., Caldarola, S., Cannata, S.M., Klinger, F.G., Di Bartolomeo, C., Mattei, M., Candi, E., De Felici, M., Melino, G. and Cesareni, G. (2009) Inhibition of the c-Abl- TAp63 pathway protects mouse oocytes from chemotherapy- induced death. Nat. Med., 15, 1179-1185.
45. Yuan, M., Luong, P., Hudson, C., Gudmundsdottir, K. and Basu, S. (2010) c-Abl phosphorylation of ΔNp63α is critical for cell viability. Cell Death Dis., doi: 10.1038/cddis.2009.15.
46. Lo Iacono, N., Mantero, S., Chiarelli, A., Garcia, E., Mills, A.A., Morasso, M.I., Costanzo, A., Levi, G., Guerrini, L. andMerlo, G.R. (2008) Regulation of Dlx5 and Dlx6 gene expression by p63 is involved in EEC and SHFM congenital limb defects. Development, 135, 1377-1388.
47. Lussier, M., Canoun, C., Ma, C., Sank, A. and Shuler, C. (1993) Interdigital soft tissue separation induced by retinoic acid in mouse limbs cultured in vitro. Int. J. Dev. Biol., 4, 555-564.
48. Beretta, C., Chiarelli, A., Testoni, B., Mantovani, R. and Guerrini, L. (2005) Regulation of the cyclin-dependent kinase inhibitor p57Kip2 expression by p63. Cell Cycle, 4, 1625-1631.
49. Sbisà, E., Mastropasqua, G., Lefkimmiatis, K., Caratozzolo, M.F., D'Erchia, A.M. and Tullo, A. (2006) Connecting p63 to cellular proliferation: the example of the adenosine deaminase target gene. Cell Cycle, 2, 205-212.
50. Ihrie, R.A., Marques, M.R., Nguyen, B.T., Horner, J.S., Papazoglu, C., Bronson, R.T., Mills, A.A. and Attardi, L.D. (2005) Perp is a p63-regulated gene essential for epithelial integrity. Cell, 120, 843-856.
51. Marinari, B., Ballaro, C., Koster, M.I., Giustizieri, M.L., Moretti, F., Crosti, F., Papoutsaki, M., Karin, M., Alema, S., Chimenti, S., Roop, D.R. and Costanzo, A. (2009) IKKalpha is a p63 transcriptional target involved in the pathogenesis of ectodermal dysplasias. J. Invest. Dermatol., 129, 60-69.
52. Lopardo, T., Lo Iacono, N., Marinari, B., Giustizieri, M.L., Cyr, D.G., Merlo, G., Crosti, F., Costanzo, A. and Guerrini, L. (2008) Claudin-1 is a p63 target gene with a crucial role in epithelial development. PLoS ONE, doi: 10.1371/journal. pone.0002715.
53. Yao, T.P., Oh, S.P., Fuchs, M., Zhou, N.D., Chng, L.E., Newsome, D., Bronson, R.T., Li, E., Livingston, D.M. and Eckner, R. (1999)Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell, 93, 361-372.
54. LeBoeuf, M., Terrell, A., Trivedi, S., Sinha, S., Epstein, J.A., Olson, E.N., Morrisey, E.E. and Millar, S.E. (2010) Hdac1 and Hdac2 act redundantly to control p63 and p53 functions in epidermal progenitor cells. Dev. Cell, 19, 807-818.
55. Merlo, G.R., Paleari, L., Mantero, S., Genova, F., Beverdam, A., Palmisano, G.L., Barbieri, O. and Levi, G. (2002) Mouse model of split hand/foot malformation type I. Genesis, 33, 97-101.
56. Chimal-Monroy, J., Abarca-Buis, R.F., Cuervo, R., Díaz- Hernández, M., Bustamante, M., Rios-Flores, J.A., Romero- Suárez, S. and Farrera-Hernández, A. (2011) Molecular control of cell differentiation and programmed cell death during digit development. Iubmb Life, 10, 922-929.
57. Nomura, N., Yokoyama, H. and Tamura, K. (2014) Altered developmental events in the anterior region of the chick forelimb give rise to avian-specific digit loss. Dev. Dyn., 6, 741-752.
58. Ghioni, P., Bolognese, F., Duijf, P.H., Van Bokhoven, H., Mantovani, R. and Guerrini, L. (2002) Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains. Mol. Cell. Biol., 22, 8659-8668.